2011 2014 2015

Have a look at the past 3 CR and commentary around completion of P3 for prevention of BV ... anyone else see this... ??

9 Dec 2015 - 32 M raised
...The funds will also support the licensing, approvals and launches of the VivaGel^® BV symptomatic relief product and the completion of the Phase 3 trials of VivaGel^® for prevention of recurrent bacterial vaginosis (BV) which are well advanced.

20 Sept 2014 -$13M raised
The funds raised will be used to support the completion of the Phase 3 trials of VivaGel® for prevention of recurrent bacterial vaginosis (BV), regulatory and commercialisation activities of VivaGel® for Symptomatic Relief of BV...

16 Nov 2011 - $32M raised
Funds raised will be used to accelerate and complete both VivaGel® Bacterial Vaginosis Phase 3 Programs (Treatment, and Prevention of Recurrence) supporting an NDA filing and commercial licence...